Pharmaceuticals · RANCHO CUCAMONGA, CA, United States
$21.60
-0.18% (-$0.04)2026-08-21
Smart-Money SignalNeutral · 47/100— Insiders are net sellers over 90 days (-$260K, 4 sales vs 6 buys)
Revenue$183.9M
Net Income$30.3M
EPS$0.81
Gross Margin50.8%
Market Cap$918.7M
Price Performance
Historical data including institutional events
Company Profile
M
Mary Z. Luo
CEO & Executive Director
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
